Navigation Links
Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients
Date:12/9/2010

t. Further, studies have demonstrated that HDAC inhibition can significantly enhance anti-cancer activity when used in combination with a broad range of anti-cancer agents. The potential therefore exists to overcome tumor resistance to targeted agents.

About Syndax Syndax Pharmaceuticals, Inc. is a Waltham, MA-based, oncology-focused pharmaceutical company. Syndax is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens. Formed in 2005, the company's intellectual property is based on work from scientific founder Ronald Evans, Ph.D., recipient of the 2004 Albert Lasker Prize for Basic Medical Research, a Member of the National Academy of Sciences, a professor at the Salk Institute for Biological Studies and a Howard Hughes Medical Institute Investigator. Syndax has worldwide rights to develop and commercialize entinostat and is backed by top-tier Venture Capital firms: Domain Associates, MPM Capital, Avalon, Pappas and Forward Ventures. For more information please visit www.syndax.com. Contact Information E. Blair Schoeb Syndax Pharmaceuticals, Inc Tel: 908-277-0386 bschoeb@syndax.com
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
2. Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
3. Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Ameritox, the nation,s leader in pain medication ... to become part of its Urine Drug Monitoring ... and improve the clinical outcomes for injured workers. ... manager in the workers, compensation industry, has used ... management strategy for several years. By establishing a ...
(Date:5/23/2013)... 2013  BioElectronics Corporation (OTC Pink: BIEL), the maker ... the FDA panel meeting for non-thermal shortwave diathermy: ... Shortwave Therapy Meeting was held on May 21, 2013 ... focus of the meeting was very narrow, in that ... on the application of non-thermal shortwave diathermy for the ...
(Date:5/23/2013)... , May 23, 2013  CAS Medical Systems, Inc. (NASDAQ: ... for non-invasive patient monitoring, today announced that Thomas ... present at the 2 nd Annual Marcum MicroCap Conference ... in New York City . ... in the Estate 10 room and will be available via ...
Breaking Medicine Technology:Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
(Date:5/23/2013)... May 23, 2013 Dr. Damon Huffman of ... suffer from gum disease a revolutionary new treatment method with ... millions of Americans who suffer from periodontal disease, and many ... treatment. Dr. Huffman is hoping that LANAP will encourage ... treatment. , Periodontal disease can cause gums ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Da Vinci ... in a trial in Washington State May 23, according ... clients in surgical robot lawsuits , expresses disappointment ... da Vinci lawsuits to not read a single verdict ... case (Estate of Fred E. Taylor v. Intuitive Surgical ...
(Date:5/23/2013)... 2013 Memorial Day Focus Spotlight on ... been a part of the U.S. Military for more ... preceding it, these men and women will be honored ... of America. As veterans transition to civilian life, ... the workplace chaplaincy world. , Marketplace Chaplains, America’s ...
(Date:5/23/2013)... Live Lead Pros , with ... best business lead solution via its smart solution ... solution features Free Web Based Account Management, Database ... and "Automatic Transfer Retry". The company has recently ... management system. , Its Free Database Usage offers ...
(Date:5/23/2013)... 23, 2013 The Rottenstein Law Group ... has created the Tylenol Lawsuit Information Center at ... users and those who are considering filing lawsuits. ... potentially cause severe liver damage, according to a 2009 ... In the “safety communication,” the FDA warned consumers against ...
Breaking Medicine News(10 mins):Health News:Humble, TX Dentist, Dr. Damon Huffman Now Offers Laser Periodontal Disease Treatment to Gum Disease Patients 2Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2
... 26, 2008 Adding noninvasive imaging to current risk-assessment ... of developing heart disease, UT Southwestern Medical Center researchers ... Southwestern-led Dallas Heart Study to determine whether using computed ... and blockages could identify more people at high risk ...
... Desso ... Turf, BRUSSELS, Belgium, May ... a few synthetic turf,fields. The fields in question are not manufactured by Desso ... that,their pitch doesn,t contain any lead., All Desso synthetic turf products and ...
... the clumps of mutant protein that drive neurodegeneration in ... make an intracellular antibody or "intrabody" against huntingtin, the ... people with Huntington,s. , Injecting the virus into the ... ability to move their limbs, although it does not ...
... mapmaker and a mathematician may seem like an unlikely duo, ... and kept millions of sailors from getting lost at ... at Rockefeller University, is making history of their own. By ... they have become the first to see, in real time ...
... Corporate Seminars Caught In Crossfire, SAN FRANCISCO, ... is not a party to a lawsuit that ... international training and,development company is inappropriately referenced in ... suit, filed by Scott Glasgow, is claiming sexual,harassment ...
... First we knew, then we didn,t. A factor, ... egg is crucial for promoting the oscillations in free ... activation processes. Phospholipase C zeta (PLCZ1) is a strong ... the zygotes pronuclei where its ability to promote calcium ...
Cached Medicine News:Health News:Increased screening may better predict those at higher risk for heart disease, researchers report 2Health News:It's Safe to Play on Desso Synthetic Turf 2Health News:It's Safe to Play on Desso Synthetic Turf 3Health News:'Intrabody' can mop up mutant protein in Huntington's disease model 2Health News:Scientists image a single HIV particle being born 2Health News:Scientists image a single HIV particle being born 3Health News:International Training and Development Company, Landmark Education, Mischaracterized as Religion 2Health News:June 2008 highlights 2
... Vision5L Digital Holter ... or 7-lead, 3-channel,Holter ... signal preview,screen. Fast ... a compact,flash card ...
... The CSV-1000CVA20/30 test face provides three contrast levels ... from 20/16 to 20/100. This test is designed ... as associated with contact lens evaluation or due ... the test provide the same contrast and acuity ...
The CSV-1000SLanC test face provides the same tests as the standard CSV-1000S, except that the acuity test is presented in Landolt C format. , ,This test is very useful when testing patients who cann...
Contrast sensitivity testing, glare sensitivity testing and ETDRS acuity testing are provided in the self standardized CSV-1000 instrument. Patented photocell circuitry automatically monitors and cal...
Medicine Products: